Brazil Conditionally Clears $825M Takeda Drug Divestment
The Brazilian competition authority said Thursday that it had cleared Hypera Pharma's bid to acquire an $825 million portfolio of over-the-counter and prescription drugs from Osaka, Japan-based Takeda Pharmaceutical Co. Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article